Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-21-055663
Date:2021-09-10
Issuer: NURIX THERAPEUTICS, INC. (NRIX)
Original Submission Date:

Reporting Person:

RING CHRISTINE
C/O NURIX THERAPEUTICS, INC.
1700 OWENS STREET, SUITE 205 SAN FRANCISCO, CA 94158

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-09-10 M 2,000 a $1.86 3,286 direct
COMMON STOCK 2021-09-10 S 700 d $35.10 2,586 direct
COMMON STOCK 2021-09-10 S 500 d $35.77 2,086 direct
COMMON STOCK 2021-09-10 S 800 d $36.76 1,286 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
EMPLOYEE STOCK OPTION (RIGHT TO BUY) 1.86 2021-09-10 deemed execution date M 2,000 (d) 2029-09-30 common stock 2,000 $1.86 105,666 direct
Footnotes
IDfootnote
f1 this transaction was effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person.
f2 represents the weighted average sale price. the lowest price at which shares were sold was $34.58 and the highest price at which shares were sold was $35.53. the reporting person undertakes to provide upon request to the staff of the securities and exchange commission, the issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this form 4.
f3 represents the weighted average sale price. the lowest price at which shares were sold was $35.64 and the highest price at which shares were sold was $35.90.
f4 the option vests as to 1/4 of the total shares on september 9, 2020, and then 1/48 of the total shares will vest monthly thereafter until the option is fully vested on august 9, 2023, subject to the reporting person's provision of service to the issuer on each vesting date. the option contains an early-exercise provision and is exercisable as to unvested shares, subject to the issuer's right of repurchase.

Elevate your investments